Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H26N2O |
| Molecular Weight | 274.4011 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(NC=C2CCN(C(C)C)C(C)C)C=C1
InChI
InChIKey=DNBPMBJFRRVTSJ-UHFFFAOYSA-N
InChI=1S/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS. | 2004 Nov |
|
| A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. | 2004 Sep |
|
| Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule. | 2004 Sep 29 |
|
| Sensitive determination of alpha-methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5MeO-DIPT) in whole blood and urine using gas chromatography-mass spectrometry. | 2005 Aug 25 |
|
| False positives and false negatives with a cocaine-specific field test and modification of test protocol to reduce false decision. | 2005 Dec 20 |
|
| A foxy intoxication. | 2005 Feb 10 |
|
| Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative. | 2006 Apr |
|
| Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. | 2006 Apr 28 |
|
| Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. | 2006 Dec 20 |
|
| Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites. | 2006 Feb |
|
| Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. | 2006 Jan |
|
| A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy. | 2006 Nov 10 |
|
| [Analysis of the chemical drugs among structural isomer]. | 2006 Sep |
|
| Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan. | 2006 Sep 26 |
|
| Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse. | 2007 Jun |
|
| Problems in three Japanese drug users with Human Immunodeficiency Virus infection. | 2008 Feb |
|
| Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy). | 2008 Jan |
|
| A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. | 2008 Jan 15 |
|
| Indolealkylamines: biotransformations and potential drug-drug interactions. | 2008 Jun |
|
| The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2. | 2008 Mar 10 |
|
| Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. | 2008 May 30 |
|
| Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats. | 2009 Jun |
|
| Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management. | 2010 Jun 24 |
|
| Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine. | 2010 Mar-Apr |
|
| The hallucinogenic world of tryptamines: an updated review. | 2015 Aug |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
7439
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
||
|
WIKIPEDIA |
TiHKAL
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-5-MeO-DiPT
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m7332
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID00193209
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY | |||
|
12D06G8W8E
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY | |||
|
DB01441
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY | |||
|
151182
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY | |||
|
4021-34-5
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY | |||
|
300000042749
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY | |||
|
48282
Created by
admin on Mon Mar 31 19:08:42 GMT 2025 , Edited by admin on Mon Mar 31 19:08:42 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)
